Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension

Cardiovasc Drugs Ther. 2024 Jun;38(3):657. doi: 10.1007/s10557-023-07431-6.

Justin K Lui^{1

2}, Ruchika A Sangani^{3

4}, Kari R Gillmeyer^{3

4}, Jasmine Vakhshoorzadeh⁴, Marcin A Trojanowski^{4

5}, Andreea M Bujor^{4

5}, Deepa M Gopal^{4

6}, Renda Soylemez Wiener^{3

4

7}, Michael P LaValley^{5

8}, Elizabeth S Klings^{3

4}

¹ The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. [email protected].
² Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. [email protected].
³ The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
⁴ Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
⁵ Section of Rheumatology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
⁶ Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
⁷ Center for Healthcare Organization & Implementation Research, VA Boston Healthcare System, Boston, MA, USA.
⁸ Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

No abstract available

Publication types